Next Article in Journal
Resveratrol Enhances the Cytotoxic Activity of Lymphocytes from Menopausal Women
Previous Article in Journal
Endothelial Adenosine Monophosphate-Activated Protein Kinase-Alpha1 Deficiency Potentiates Hyperoxia-Induced Experimental Bronchopulmonary Dysplasia and Pulmonary Hypertension
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 10
Issue 12
10.3390/antiox10121915
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chlorogenic Acid Attenuates Oxidative Stress-Induced Intestinal Epithelium Injury by Co-Regulating the PI3K/Akt and IκBα/NF-κB Signaling

by
Jiali Chen
1,2,†,
Yuheng Luo
1,2,†,
Yan Li
1,3,
Daiwen Chen
1,2,
Bing Yu
1,2 and
Jun He
1,2,*
1
Institute of Animal Nutrition, Sichuan Agricultural University, Chengdu 611130, China
2
Key Laboratory of Animal Disease-Resistance Nutrition of the Ministry of Agriculture, Chengdu 611130, China
3
Guilin Fengpeng Bio-Tech Co., Ltd., Guilin 541199, China
*
Author to whom correspondence should be addressed.
†
The authors contributed equally to this work.
Antioxidants 2021, 10(12), 1915; https://doi.org/10.3390/antiox10121915
Submission received: 29 October 2021 / Revised: 24 November 2021 / Accepted: 27 November 2021 / Published: 29 November 2021
Browse Figures
Versions Notes

Abstract

:
Chlorogenic acid (CGA) is a natural polyphenol compound abundant in green plants with antioxidant and anti-inflammatory activities. Here, we explore its protective effects and potential mechanisms of action on intestinal epithelium exposure to oxidative stress (OS). We show that CGA attenuated OS-induced intestinal inflammation and injury in weaned pigs, which is associated with elevated antioxidant capacity and decreases in inflammatory cytokine secretion and cell apoptosis. In vitro study showed that CGA elevated phosphorylation of two critical signaling proteins of the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) pathway, Akt and nuclear factor erythroid-derived-related factor 2, leading to the elevated expression of intracellular antioxidant enzymes and heme oxygenase-1 (HO-1). Specific inhibition of HO-1 partially abolished its anti-inflammatory effect in IPEC-J2 cells exposure to OS. Interestingly, CGA suppressed the tumor necrosis factor-α (TNF-α) induced inflammatory responses in IPEC-J2 cells by decreasing phosphorylation of two critical inflammatory signaling proteins, NF-kappa-B inhibitor alpha (IκBα) and nuclear factor-κB (NF-κB). Specific inhibition of HO-1 cannot fully abolish its anti-inflammatory effect on the TNF-α-challenged cells. These results strongly suggested that CGA is a natural anti-inflammatory agent that can attenuate OS-induced inflammation and injury of intestinal epithelium via co-regulating the PI3K/Akt and IκBα/NF-κB signaling pathway.

1. Introduction

Oxidative stress (OS) is a physiological status characterized by an elevation of oxygen reactive species (ROS) in cells and tissues [1,2]. ROS are unstable and active oxygen-centered molecules containing unpaired valence-shell electrons. Under normal conditions, animals and humans possess effective capabilities of the generation and elimination of ROS. However, regardless of the endogenous sources, pollutants, radiation, diet, and lifestyle all can contribute to the elevation of intracellular ROS, leading to OS [3]. Importantly, increase in cellular ROS not only leads to frequent reactions with cell components, such as proteins, fats, and DNA, but also triggers various OS-related signaling pathways that are directly linked to tissue injury or the development of diseases [4,5,6,7]. Moreover, OS and inflammation are two closely interrelated and interdependent pathophysiological processes. ROS can initiate intracellular signaling cascades that upregulate the expression of proinflammatory genes [8]. On the other hand, inflammatory cells can secrete ROS and various immune mediators (e.g., cytokines and chemokines) leading to induction of OS and tissue damage at the site of inflammation [9].
The intestinal epithelium is the main site for nutrient absorption and provides a primary physical barrier against commensal and pathogenic microorganisms in the intestine. It has also been regarded as one of the major sources of ROS production, as the intestinal epithelium has inevitable exposure to exogenous substance and microbial pathogens [4]. Despite the protective barrier provided by the epithelial layer, ingested materials and pathogens can cause inflammation by activating the epithelium, polymorphonuclear neutrophils, and macrophages to produce inflammatory cytokines and other mediators that contribute further to OS. Importantly, various gastrointestinal diseases, including peptic ulcers, gastrointestinal cancers, and inflammatory bowel diseases, arise in part due to OS [4,10,11]. Thus, maintaining the ROS balance is urgently needed for the maintaining of intestinal health and for the treatment of associated intestinal diseases.
Chlorogenic acid (CGA), formed by esterification of caffeic acid and quinic acid, is one of the most abundant natural polyphenols present in coffee, fruits, and vegetables [12]. It also serves as a major active component in many Chinese medicinal herbs, such as Eucommia, Honeysuckle, and Lonicera japonica [13]. Previous studies indicated that CGA has multiple biological functions, including antioxidant, anti-inflammatory, and immunoprotective activities [14,15,16]. By far, many studies have been done to evaluate the potential health-promoting effects of CGA, indicating the beneficial effects of CGA on reducing the risk of metabolic syndrome or associated disorders, including diabetes, obesity and hypertension [17,18]. In addition, CGA was found to decrease the intestinal permeability and ameliorate intestinal injury in rat exposure to OS [19]. Our recent study also shows that CGA can attenuate weaning stress-induced intestinal injury in pigs by enhancing the activities of antioxidant enzymes and suppressing intestinal inflammatory cytokines [20]. However, the molecular mechanism of CGA action still remains unclear.
Diquat is a classic OS inducer, which is readily converted to a free radical in the presence of molecular oxygen, and subsequently produces superoxide anions and other redox products [21,22]. Therefore, to clarify the exact role of CGA and its mechanism of action, we explored the protective effect of CGA on intestinal epithelium in a porcine model exposure to OS induced by diquat [23]. We also investigated the protective potential of CGA against intestinal epithelium injury induced by diquat or tumor necrosis factor-α (TNF-α) in the porcine jejunal epithelial cell line IPEC-J2, to prove its effectiveness even when administered in vitro. Here, we report convincing evidence on the novel antioxidant effect of CGA and provide key insights into its potential mechanisms of action.

2. Materials and Methods

2.1. Reagents

Chlorogenic acid (Cat no. C3878, purity ≥ 95%) and diquat (Cat no. 45422) was purchased from Sigma (Sigma–Aldrich, Shanghai, China). Dulbecco’s Modified Eagle’s Medium and Ham’s F-12 Nutrient Mixture (DMEM/F12) medium and fetal bovine serum were obtained from HyClone (Logan UT, USA). TNF-α was purchased from RayBiotech (Norcross, GA, USA). LY294002 (Cat no. Z274722) and (E)3-[(4-methylphenyl)-sulfonyl]-2-propenenitrile (BAY11-7082) were purchased from Selleck (Selleckchem, Shanghai, China). Zn-protoporphyrin-IX (ZnPPIX, Cat no. 14483) was purchased from Cayman (Cayman Chemical, Beijing, China).

2.2. Animal Trial and Sample Collection

The OS was induced by using the diquat [23]. Twenty-four weaned pigs (Duroc × Landrace × Yorkshire), with an initial average body weight (BW) of 7.47 ± 0.50 kg, were randomly allotted to three groups (n = 8): (1) non-challenged control (CON; pigs fed with basal diet); (2) diquat-challenged control (diquat; pigs fed with basal diet and challenged by diquat); (3) diquat challenge + CGA treatment (DCGA; pigs fed with basal diet (Table S1) containing 1000 mg/kg CGA and challenged by diquat). The supplementary level of CGA to feed was based on our previous study [24]. Pigs were housed individually for 21 d in metabolism cages (0.70 × 1.50 m) and had free access to feed and water in an environmentally controlled house. On 15 d, pigs were either challenged by sterile saline or diquat (10 mg/kg BW) via intraperitoneal injection [23]. At the end of the trial, blood was collected from pigs after 12-h fasting. The serum samples were obtained by centrifugation at 3000× g for 15 min at 4 °C, and were subsequently stored at −20 °C for further analysis. Following blood collection, the pigs were euthanized with an intravenous injection of sodium pentobarbital (200 mg/kg body weight), and the abdomen was immediately opened to collect the jejunal segments. Briefly, about 2-cm segments of the middle jejunum were isolated, gently flushed with ice-cold phosphate buffer saline (PBS), and then preserved with ice-cold PBS for flow cytometry. Additionally, another 3-cm of segment was fixed in 4% paraformaldehyde solution for immunofluorescence and histological analyses. The mucosa samples were harvested by scraping the segment using a sterile glass slide, and were snap-frozen in liquid nitrogen and then stored at −80 °C until further analysis.

2.3. Cell Culture

The porcine jejunal epithelial cell line IPEC-J2 was obtained from American Type Culture Collection and cultured in DMEM/F12 medium supplemented with 10% fetal bovine serum, 100 IU/mL of penicillin, 100 mg/mL of streptomycin, 5 mg/mL epidermal growth factor, and 10 nM N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid, at 37 °C in a humidified atmosphere of 5% CO2. All cells were washed with PBS (pH 7.2–7.4) before treatment with CGA, diquat, or TNF-α. After growing in 80% confluence in 6-well plates, the cells (pretreated with 100 µM CGA for 6 h) were exposed to 100 µM diquat for 3 h, or the cells (pretreated with 50 µM CGA for 6 h) were exposed to 50 ng/mL TNF-α for 3 h. The culture supernatants and pellets were collected and stored in −80 °C for further analysis. Cell viability was analyzed by using the cell counting kit-8 with a microplate reader (SpectraMax M2, Molecular Devices, Sunnyvale, CA, USA).

2.4. Flow Cytometric Assays

Cellular apoptosis was assessed by using fluorescein isothiocyanate (FITC)-, Alexa Fluor®647-conjugated Annexin V with propidium iodide (PI) staining assay (Biolegend; 640914 and 610912) according to the manufacturer’s instructions. Briefly, cells were harvested and resuspended in 100 μL/106 cells of 1 × binding buffer. After that, 2 μL of Annex V per test were added and incubated for 20 min in the dark on ice. Subsequently, 400 μL 1× binding buffer and 1 μL PI (1 mg/mL) was added into the reaction tubes and then mixed thoroughly. The apoptotic cells were immediately measured by flow cytometry and analyzed with FlowJo software (FlowJoLLC).

2.5. Immunofluorescence Assays

The distribution of the tight junction protein (claudin-1) in the intestinal epithelium and IPEC-J2 cells was determined by using immunofluorescence analysis. Briefly, the jejunal segments were deparaffinized and then subjected to antigen retrieval by ethylene diamine tetraacetic acid (1 M, pH 9.0). Sections were blocked with 3% bovine serum albumin and incubated with rabbit anti-claudin-1 antibody (1:100 dilution; Abcam plc., Cambridge, UK) overnight at 4 °C. The sections were washed three times with PBS (pH 7.4), and then treated by goat anti-rabbit IgG-FITC secondary antibody (Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China), followed by incubation at room temperature for 50 min in the dark. Sections were then washed with PBS (PH 7.4), and the nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI) for 10 min at room temperature. For in vitro studies, the cultured cells were fixed with 4% paraformaldehyde solution, and then 0.5% Triton X-100 was used for the permeation of the cells. After the successive incubation with the first and second antibodies, DAPI was added for the generation of fluorescence. The slides were visualized under a laser scanning confocal microscope (FV1000; Olympus Corporation, Tokyo, Japan).

2.6. Intracellular ROS Assays

The content of intracellular ROS was measured by using the ROS detection kit (ab113851, Abcam). Briefly, after specific experimental treatment, the culture medium was discarded and then incubated with 10 μL of 2′,7′-Dichlorodihydrofluorescein diacetate for 1 h at 37 °C. Cells were washed thrice with PBS and then resuspended in PBS. Finally, the intracellular ROS level was examined with a NanoDrop spectrophotometer (Beckman Coulter DU800; Beckman Coulter Inc., Fullerton, CA, USA) at the excitation wavelength of 500 (500 ± 15 nm) and the optimal emission wavelength of 525 (530 ± 20 nm).

2.7. Western Blotting Analysis

Proteins were extracted from IPEC-J2 cells by using the RIPA lysis buffer. Protein concentrations were determined by using the bicinchoninic acid assay kit (ab102536, Abcam) and Nano-Drop ND 2000c Spectrophotometer (Thermo Scientific, Waltham, MA, USA). Equal amounts of proteins were resolved through sodium dodecyl sulfate polyacrylamide gel electrophoresis on 10% polyacrylamide gels, and then transferred onto polyvinylidene fluoride (PVDF) membrane (Millipore, Eschborn, Germany) with a wet Trans-Blot system (Bio-Rad, Richmond, CA, USA). After blocked with 0.1% Tris-buffered saline (TBS/T) supplemented with 5% bovine serum albumin for 1 h at room temperature, the membranes were incubated in specific primary antibodies [protein kinase B (Akt, CST, 9272), pAkt (CST, 9271), nuclear factor erythroid-derived-related factor 2 (Nrf2, Cayman, ab137550), pNrf2 (Cayman, ab76026), heme oxygenase-1 (HO-1, Cayman, ab13248), nuclear factor-κBp65 (NF-κBp65, CST, 6956), pNF-κBp65 (CST, 3033), NF-kappa-B inhibitor alpha (IκBα, CST, 4814), pIκBα (CST, 8219) and β-actin (Santa Cruz, 47778)] at 4 °C overnight (1:1000 dilution). The PVDF membranes were washed with TBS/T and then incubated with second antibodies for 1 h at room temperature. The second goat anti-rabbit and goat anti-mouse antibodies conjugated to horseradish peroxidase (Santa Cruz, sc-2030 and sc-2031) was used (1:3000 dilution). Signal densities of the immunoblotting image were determined using ClarityTM Western ECL Substrate (Bio-Rad, Hercules, CA, USA) on a ChemiDocTM XRS+ Imager System (Bio-Rad).

2.8. RNA Extraction and QPCR

Total RNA was extracted from the cells by using the Trizol reagent (TaKaRa, Dalian, China) following the manufacturer’s instructions. The purity and concentration of all RNA samples were checked by a NanoDrop spectrophotometer (Beckman Coulter DU800; Beckman Coulter Inc., Fullerton, CA, USA) at 260 and 280 nm. Reverse transcription was performed using the PrimeScripte RT reagent kit with gDNA Eraser (TaKaRa, Dalian, China). All primers were synthesized commercially by Sangon Biotech Limited and were shown in Table S2. The expression levels of genes were detected by using the CFX-96 Real-Time PCR Detection System (Bio-Rad Laboratories, Richmond, CA, USA) and SYBR Premix Ex Taq II (Tli RNaseH Plus) reagents (TaKaRa, Dalian, China). The glyceraldehyde-3-phosphate dehydrogenase was used as the house-keeping gene to normalize the expression of target genes. Relative expression was calculated using the comparative cycle threshold (2−ΔΔCt) method [25].

2.9. Biochemical Analysis

Serum xylose concentration was determined by using the xylose detection kit (Jiancheng Bioengineering Institute, Nanjing, China) with a spectrophotometer (Beckman Coulter DU-800; Beckman Coulter, Inc.). Tissues or cells were homogenized in ice with RIPA lysis buffer. Antioxidant-related kits from Nanjing Jiancheng Bioengineering Institute were used to determine the content of the malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px), and total antioxidative capability (T-AOC) according to the manufacturers’ instructions.

2.10. Statistical Analysis

All results are expressed as the means and standard deviation. Data were subjected to one-way analysis of variance (ANOVA) followed by Tukey’s multiple-range test to determine significant differences among the treatments at p < 0.05 with SAS 9.0 software (SAS Inst. Inc., Cary, NC, USA).

3. Results

3.1. CGA Attenuates OS-Induced Inflammation and Intestinal Epithelium Injury in Weaned Pigs

Our previous study showed that CGA could enhance the intestinal antioxidant and anti-inflammatory capacities of weaned pigs [20]. To further explore the protective effect of CGA, weaned pigs were treated with or without CGA, and subsequently exposed to OS (diquat challenge) in the present study. Results showed that diquat challenge significantly decreased the body weight and led to injury of the intestinal epithelium, as indicated by decreased villus height and reduced absorption of xylose (Figure 1A–D). Immunofluorescence also showed that diquat challenge decreased the abundance of the tight-junction protein (claudin-1). However, CGA supplementation not only improved the integrity of the intestinal epithelium, but also significantly reduced the apoptosis of the intestinal epithelial cells upon diquat challenge (Figure 1E). Interestingly, CGA supplementation elevated the activity of antioxidant enzymes, such as the GSH-Px and CAT, but significantly decreased the content of MDA and inflammatory cytokines, such as the interleukin-1β (IL-1β) and TNF-α in the intestinal mucosa upon diquat challenge (Figure 1F,G).

3.2. Protective Effect of CGA on IPEC-J2 Cell Exposure to OS

We next investigated the protective potential of CGA against diquat-induced OS and injury in IPEC-J2. The IPEC-J2 cells were pretreated with CGA and then challenged by diquat. Results showed that diquat challenge significantly decreased the cell viability and the abundance of tight-junction proteins (Figure 2A–C). Moreover, the diquat challenge elevated the apoptosis rate in the IPEC-J2 cells. However, CGA pretreatment not only improved the integrity of the cells, but also reduced the number of apoptotic cells upon diquat challenge (Figure 2D). CGA had no influences on cellular ROS and antioxidant enzyme in the IPEC-J2 cells without being diquat-challenged. However, CGA pretreatment significantly reduced the cellular ROS and MDA content, but increased the SOD content in the diquat-challenged cells (Figure 2E). As the OS and inflammation are two closely interrelated and interdependent pathophysiological processes [19,20], we next investigated the expression levels of several critical molecules involved in the inflammatory response. As shown in Figure 2F, diquat challenge significantly elevated the expression levels of monocyte chemotactic protein-1 (MCP-1), IL-1β, and TNF-α in the IPEC-J2 cells. However, CGA pretreatment significantly down-regulated their expressions in the diquat-challenged cells. Nrf2 and HO-1 are two critical regulators involved in the cellular antioxidative responses [16,26]. We found that CGA pretreatment significantly elevated their protein abundance in the diquat-challenged cells (Figure 2G).

3.3. CGA Attenuates OS-Induced Injury in IPEC-J2 Cells via phosphatidylinositol-3-kinase (PI3K)/Akt Signaling

Activation of the PI3K/Akt signaling results in the translocation of Nrf2 and transcription of genes coding a series of cellular antioxidant enzymes [27]. To verify the effectiveness of CGA and the potential mechanisms of action, a specific inhibitor (LY294002) of the PI3K/Akt signaling was used in this study. We show that treating the cells with LY294002 alone had no influences on cell viability, tight junction protein, and cell apoptosis in the diquat-challenged cells. However, pretreatment of the cells with LY294002 abolished the protective effect of CGA on diquat-challenged cells, as indicated by the decreased abundance of tight junction protein and cell viability, and elevated apoptosis rate (Figure 3A–D). Moreover, LY294002 abolished the antioxidant capacity of CGA, as indicated by the increased ROS and MDA content, and the decreased SOD content in the diquat-challenged cells (Figure 3E). We also investigated the abundances of critical signaling proteins involved in the PI3K/Akt signaling pathway. As expected, CGA not only elevated the abundances of the phosphorylated Akt and Nrf2, but also elevated the protein abundance of HO-1 in the diquat-challenged cells. However, the LY294200 (combined with CGA or alone) significantly decreased their abundances in the IPEC-J2 upon diquat challenge (Figure 3F).

3.4. CGA-Regulated HO-1 Expression Suppresses IκBα/NF-κB Signaling in IEPC-J2 Cell Exposure to OS

HO-1 is one of the downstream targets of the Nrf2 and acts as a critical regulator of the cellular stress response and inflammation [28]. We found that treating the cells with a specific inhibitor of HO-1 (ZnPPIX) abolished the protective effect of CGA in the diquat-challenged cells, as indicated by increased apoptosis rate and elevated expressions of inflammatory cytokines (Figure 4A,B). IκBα and NF-κB are two critical inflammation-associated signaling proteins that are regulated by various upstream regulators, including the HO-1 [28,29]. In the present study, CGA treatment significantly reduced the protein abundances of phosphorylated IκBα and NF-κB in the diquat-challenged cells. However, specific inhibiting of the HO-1 abolished the inhibitory effects of CGA on the two critical signaling proteins (Figure 4C,D).

3.5. CGA Attenuates TNF-α Induced Injury in IPEC-J2 Cells via Direct Suppressing of the IκBα/NF-κB Signaling

As the OS and inflammation are two closely interrelated pathophysiological processes, we next investigated the protective effect of CGA on inflammation-induced injury in the IPEC-J2 cells upon TNF-α challenge. We show that TNF-α challenge led to injury of the cells, as indicated by increases in cell apoptosis and expressions of a critical inflammation- or apoptosis-related molecules, such as the MCP-1, IL-1β, IL-6, Bax, and caspase3/9 (Figure 5A–E). However, CGA treatment significantly attenuated injury and inflammatory responses in the IPEC-J2 cells exposure to TNF-α. Importantly, CGA significantly decreased the protein abundances of phosphorylated IκBα and NF-κB in the TNF-α-challenged cells (Figure 5F). Moreover, specific inhibiting of the NF-κB (using BAY11-7082) also attenuated injury and inflammatory responses in cells exposure to TNF-α (Figure 6). However, specific inhibiting of the HO-1 did not abolish the protective effect of CGA on the TNF-α-challenged cells.

4. Discussion

The gastrointestinal (GI) tract is a key source of ROS generation, as the gastrointestinal mucosa is constantly challenged by diet-derived oxidants, mutagens, and carcinogens as well as by the endogenously generated ROS [30]. ROS are key signaling molecules that play an important role in the progression of many inflammatory disorders [9]. Evidence is accumulating to show that various GI pathological conditions, including gastroduodenal ulcers, GI malignancies, and inflammatory bowel disease, arise in part from OS [4,31]. Diquat, a classic OS inducer, can be readily converted to a free radical in the presence of molecular oxygen and subsequently generates superoxide anions and other redox products. [21,22]. In the present study, diquat challenge induced intestinal inflammation and impaired the intestinal epithelial functions (e.g., increased apoptosis of the intestinal epithelial cells) both in vivo and in vitro. However, CGA not only reduced generation of intracellular ROS, but also attenuated the OS-induced inflammation and injury, indicating the prominent antioxidative property of the natural polyphenols.
Although the free radicals are continuously generated, the antioxidant defense system in the body can help to defend against the harmful effects of ROS. Currently, several mechanisms mediating protection against OS are documented [5]. Amongst these mechanisms, the PI3K/Akt signaling pathway has been considered the most important one in the regulation of OS, and activation of this signaling pathway results in the translocation of Nrf2 and transcription of genes coding a series of cellular antioxidant enzymes [32,33]. In the present study, CGA treatment attenuated OS-induced injury and significantly elevated the abundances of phosphorylated Akt and Nrf2 in the IPEC-J2 cells. As expected, the intracellular SOD content was significantly elevated in the diquat-challenged cells after CGA treatment. SOD is one of the major antioxidant enzymes for mammalian animals, including the human. Currently, three distinct isoforms of SOD have been identified and characterized in mammals: copper–zinc superoxide dismutase (Cu/ZnSOD), manganese superoxide dismutase (MnSOD), and extracellular superoxide dismutase (ECSOD), and they elicit similar functions [34,35]. However, treatment of the cells with a specific PI3K inhibitor abolished the protective effect of CGA against the OS, as indicated by increased cell apoptosis and ROS generation. The result suggested that CGA may attenuate the OS-induced injury via regulating the PI3K/Akt signaling pathway.
Activation of the Nrf2 represents a cellular defense response against OS. Previous study indicated that Nrf2 activates a transcription of a wide variety of genes involved in redox balance, detoxification of xenobiotics, metabolism, and inflammation [36]. HO-1, a rate-limiting enzyme of heme degradation, is an endogenous, cytoprotective enzyme that is activated by Nrf2 during cellular OS [37]. Importantly, numerous studies indicated that HO-1 plays a critical role in maintain antioxidant/oxidant homeostasis and inducing immunomodulatory, anti-inflammatory, and antiapoptotic effects [37,38,39]. In the present study, CGA significantly elevated the abundances of phosphorylated Nrf2 and HO-1 in the diquat-challenged cells, and attenuated its inflammatory responses as indicated by decreases in cell apoptosis, secretion of inflammatory cytokines, and abundances of phosphorylated IκBα and NF-κB. However, treating the cells with a specific HO-1 inhibitor abolished its anti-inflammatory effect. Previous studies indicated that Nrf2/HO-1 downregulates the function of antigen-presenting cells, polarizes macrophages into anti-inflammatory phenotype (M2), and reduces detrimental immune activation [40,41,42]. Moreover, Nrf2/HO-1 and its metabolites may also modulate humoral immunity thus reducing the production of autoantibodies [43,44]. These results suggested that CGA could suppress the OS-induced inflammation and injury in the intestinal epithelium through indirect inhibition of the IκBα/NF-κB signaling pathway activation by promoting the expression of HO-1 via PI3K/Akt signaling pathway.
To further study the effect of CGA on the activation of IκBα/NF-κB signaling pathway, we also explored the protective effect of CGA on cellular inflammation that is independent on OS in the IPEC-J2 cells. TNF-α is a classic pro-inflammatory cytokine that can mediate host inflammatory response to various pathogens [45]. Importantly, overproduction of TNF-α not only increases the permeability of intestinal epithelium, but also induces apoptosis via the intrinsic mitochondrial apoptotic pathway [46,47]. In the present study, we found that CGA can exert a similar role to that of specific NF-κB inhibitor (BAY11-7082) and both can attenuate TNF-α induced inflammation and injury in the IPEC-J2 cells (as indicated by the decreases in cell apoptosis and expressions of critical inflammation-related molecules, such as the IκBα and NF-κB). However, specific inhibition of the HO-1 cannot fully abolish its anti-inflammatory effects, indicating that CGA can suppress the inflammation and injury of intestinal epithelium by inhibiting the activation of IκBα/NF-κB signaling pathway that is independent on the PI3K/Akt-Nrf2 signaling pathway.

5. Conclusions

In summary, the present study provides novel insights into the inhibiting effects of CGA on OS-induced intestinal inflammation and epithelium dysfunction. The mechanisms of action might be associated with co-regulating the PI3K/Akt and IκBα/NF-κB signaling pathway (Figure 7). The antioxidant and anti-inflammatory properties of CGA should make it an attractive candidate for the prevention or treatment of various OS-induced injuries and diseases.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/antiox10121915/s1, Table S1: Ingredient composition and nutrient levels of basal diets (air-dry basis, %), Table S2: Primers used for real-time quantitative PCR.

Author Contributions

J.C. and J.H. conceived and designed the experiments; J.C., Y.L. (Yuheng Luo) and Y.L. (Yan Li) performed the experiments; D.C. and B.Y. analyzed the data; J.C. and Y.L. (Yuheng Luo) wrote the paper; D.C., B.Y. and J.H. helped revise the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Key Research and Development Program of Sichuan Province (2020YFN0147) and the National Natural Science Foundation of China (31972599).

Institutional Review Board Statement

Experimental procedures were approved by the Animal Care and Use Committee of Sichuan Agricultural University (SICAU-2015-034) and were in accordance with the National Research Council’s Guide for Care and Use of Laboratory Animals.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data presented in this study are presented in the article and supplementary material.

Acknowledgments

We thank Huifen Wang and Quyuan Wang for their help during the animal trial and sample collections.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Egea, G.; Jiménez-Altayó, F.; Campuzano, V. Reactive oxygen species and oxidative stress in the pathogenesis and progression of genetic diseases of the connective tissue. Antioxidants 2020, 9, 1013. [Google Scholar] [CrossRef]
  2. Hohn, A.; Weber, D.; Jung, T.; Ott, C.; Hugo, M.; Kochlik, B.; Kehm, R.; Konig, J.; Grune, T.; Castro, J.P. Happily (n) ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence. Redox Biol. 2017, 11, 482–501. [Google Scholar] [CrossRef] [PubMed]
  3. Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.M.; Tossou, C.; Rahu, N. Oxidative stress and inflammation: What polyphenols can do for us? Oxid. Med. Cell. Longev. 2016, 2016, 7432797. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Bhattacharyya, A.; Chattopadhyay, R.; Mitra, S.; Crowe, S.E. Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol. Rev. 2014, 94, 329–354. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Finkel, T.; Holbrook, N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408, 239–247. [Google Scholar] [CrossRef] [PubMed]
  6. Patel, R.S.; Ghasemzadeh, N.; Eapen, D.J.; Sher, S.; Arshad, S.; Ko, Y.A.; Veledar, E.; Samady, H.; Zafari, A.M.; Sperling, L.; et al. Novel biomarker of oxidative stress is associated with risk of death in patients with coronary artery disease. Circulation 2016, 133, 361–369. [Google Scholar] [CrossRef]
  7. Wei, Y.H.; Lee, H.C. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp. Biol. Med. 2002, 227, 671–682. [Google Scholar] [CrossRef] [PubMed]
  8. Hald, A.; Lotharius, J. Oxidative stress and inflammation in Parkinson’s disease: Is there a causal link? Exp. Neurol. 2005, 193, 279–290. [Google Scholar] [CrossRef]
  9. Mittal, M.; Siiqui, M.R.; Tran, K.; Redy, S.P.; Malik, A.B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal 2014, 20, 1126–1167. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Sturm, C.; Wagner, A.E. Brassica-derived plant bioactives as modulators of chemopreventive and inflammatory signaling pathways. Int. J. Mol. Sci. 2017, 18, 1890. [Google Scholar] [CrossRef] [Green Version]
  11. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.; Mazur, M.; Telser, J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell. Biol. 2007, 39, 44–84. [Google Scholar] [CrossRef] [PubMed]
  12. Bouayed, J.; Rammal, H.; Dicko, A.; Younos, C.; Soulimani, R. Chlorogenic acid, a polyphenol from Prunus domestica (Mirabelle), with coupled anxiolytic and antioxidant effects. J. Neurol. Sci. 2007, 262, 77–84. [Google Scholar] [CrossRef] [PubMed]
  13. Zhang, B.; Nan, T.; Zhan, Z.; Kang, L.; Yang, J.; Lai, C.; Yuan, Y.; Wang, B.; Huang, L. A monoclonal antibody-based enzyme-linked immunosorbent assay for the determination of chlorogenic acid in honeysuckle. J. Pharm. Biomed. 2018, 148, 1–5. [Google Scholar] [CrossRef] [PubMed]
  14. Ye, H.Y.; Jin, J.; Jin, L.W.; Chen, Y.; Zhou, Z.H.; Li, Z.Y. Chlorogenic acid attenuates lipopolysaccharide-induced acute kidney injury by inhibiting TLR4/NF-κB signal pathway. Inflammation 2017, 40, 523–529. [Google Scholar] [CrossRef] [PubMed]
  15. Wang, D.; Tian, L.; Lv, H.; Pang, Z.; Li, D.; Yao, Z.; Wang, S. Chlorogenic acid prevents acute myocardial infarction in rats by reducing inflammatory damage and oxidative stress. Biomed. Pharmacother. 2020, 132, 110773. [Google Scholar] [CrossRef] [PubMed]
  16. Zheng, R.; Liu, S.; Zhou, Y.; Mi, S.; Liu, G.; Wu, X.; Yao, K.; Assaad, H.; Deng, Z.; Hou, Y.; et al. Chlorogenic acid decreases intestinal permeability and increases expression of intestinal tight junction proteins in weaned rats challenged with LPS. PLoS ONE 2014, 9, e97815. [Google Scholar]
  17. Kumar, R.; Sharma, A.; Iqbal, M.S.; Srivastava, J.K. Therapeutic promises of chlorogenic acid with special emphasis on its anti-obesity property. Curr. Mol. Pharmacol. 2020, 13, 7–16. [Google Scholar] [CrossRef] [PubMed]
  18. Ward, N.C.; Hodgson, J.M.; Woodman, R.J.; Zimmermann, D.; Poquet, L.; Leveques, A.; Actis-Goretta, L.; Puddey, I.B.; Croft, K.D. Acute effects of chlorogenic acids on endothelial function and blood pressure in healthy men and women. Food Funct. 2016, 7, 2197–2203. [Google Scholar] [CrossRef] [Green Version]
  19. Sato, Y.; Itagaki, S.; Kurokawa, T.; Ogura, J.; Kobayashi, M.; Hirano, T.; Sugawara, M.; Iseki, K. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int. J. Pharm. 2011, 403, 136–138. [Google Scholar] [CrossRef]
  20. Chen, J.; Yu, B.; Chen, D.; Huang, Z.; Mao, X.; Zheng, P.; Yu, J.; Luo, J.; He, J. Chlorogenic acid improves intestinal barrier functions by suppressing mucosa inflammation and improving antioxidant capacity in weaned pigs. J. Nutr. Biochem. 2018, 59, 84–92. [Google Scholar] [CrossRef]
  21. Jones, G.M.; Vale, J.A. Mechanisms of toxicity, clinical features, and management of diquat poisoning: A review. J. Toxicol. Clin. 2000, 38, 123–128. [Google Scholar] [CrossRef] [PubMed]
  22. Koch, R.E.; Hill, G.E. An assessment of techniques to manipulate oxidative stress in animals. Funct. Ecol. 2017, 31, 9–21. [Google Scholar] [CrossRef] [Green Version]
  23. Zheng, P.; Yu, B.; He, J.; Yu, J.; Mao, X.; Luo, Y.; Luo, J.; Huang, Z.; Tian, G.; Zeng, Q.; et al. Arginine metabolism and its protective effects on intestinal health and functions in weaned piglets under oxidative stress induced by diquat. Br. J. Nutr. 2017, 117, 1495–1502. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Chen, J.; Li, Y.; Yu, B.; Chen, D.; Mao, X.; Zheng, P.; Luo, J.; He, J. Dietary chlorogenic acid improves growth performance of weaned pigs through maintaining antioxidant capacity and intestinal digestion and absorption function. J. Anim. Sci. 2018, 96, 1108–1118. [Google Scholar] [CrossRef] [PubMed]
  25. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef]
  26. Jin, C.H.; So, Y.K.; Han, S.N.; Kim, J.B. Isoegomaketone upregulates heme oxygenase-1 in RAW264.7 cells via ROS/p38 MAPK/Nrf2 pathway. Biomol. Ther. 2016, 24, 510–516. [Google Scholar] [CrossRef] [Green Version]
  27. Kobayashi, M.; Yamamoto, M. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid. Redox Signal. 2005, 7, 385–394. [Google Scholar] [CrossRef]
  28. Foresti, R.; Bains, S.K.; Pitchumony, T.S.; de Castro Bras, L.E.; Drago, F.; Duboios-Rande, J.L.; Bucolo, C.; Motterlini, R. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. Pharmacol. Res. 2013, 76, 132–148. [Google Scholar] [CrossRef] [Green Version]
  29. Yeh, P.Y.; Li, C.Y.; Hsieh, C.W.; Yang, Y.C.; Yang, P.M.; Wung, B.S. CO-releasing molecules and increased heme oxygenase-1 induce protein S-glutathionylation to modulate NF-κB activity in endothelial cells. Free Radic. Biol. Med. 2014, 70, 1–13. [Google Scholar] [CrossRef]
  30. Ames, B. Dietary carcinogens and anticarcinogens. Science 1983, 221, 1256–1263. [Google Scholar] [CrossRef] [Green Version]
  31. Chu, F.F.; Esworthy, R.S.; Doroshow, J.H. Role of Se-dependent glutathione peroxidases in gastrointestinal inflammation and cancer. Free Radic. Biol. Med. 2004, 36, 1481–1495. [Google Scholar] [CrossRef] [PubMed]
  32. Noshita, N.; Sugawara, T.; Lewen, A.; Hayashi, T.; Chan, P.H. Copper-zinc superoxide dismutase affects Akt activation after transient focal cerebral ischemia in mice. Stroke 2003, 34, 1513–1518. [Google Scholar] [CrossRef] [Green Version]
  33. Rojo, A.E.; Salinas, M.; Martin, D.; Perona, R.; Cuadrado, A. Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-κB. J. Neurosci. 2004, 33, 7324–7334. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Miao, L.; Clair, D.K.S. Regulation of superoxide dismutase genes: Implications in disease. Free Radic. Biol. Med. 2009, 47, 344–356. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Parge, H.E.; Hallewell, R.A.; Tainer, J.A. Atomic structures of wild-type and thermostable mutant recombinant human Cu, Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA 1992, 89, 6109–6113. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Alcaraz, M.J.; Ferrandiz, M.L. Relevance of Nrf2 and heme oxygenase-1 in articular diseases. Free Radic. Biol. Med. 2020, 157, 83–93. [Google Scholar] [CrossRef]
  37. Hada, Y.; Uchida, H.A.; Otaka, N.; Onishi, Y.; Okamoto, S.; Nishiwaki, M.; Takemoto, R.; Takeuchi, H.; Wada, J. The protective effect of chlorogenic acid on vascular senescence via the Nrf2/HO-1 pathway. Int. J. Mol. Sci. 2020, 21, 4527. [Google Scholar] [CrossRef]
  38. Ryter, S.W.; Choi, A.M. Heme oxygenase-1/carbon monoxide: From metabolism to molecular therapy. Am. J. Respir. Cell. Mol. Biol. 2009, 41, 251–260. [Google Scholar] [CrossRef] [Green Version]
  39. Choi, A.M.; Otterbein, L.E. Emerging role of carbon monoxide in physiologic and pathophysiologic states. Antioxid. Redox Sign. 2002, 4, 227–228. [Google Scholar] [CrossRef]
  40. Hull, T.D.; Agarwal, A.; George, J.F. The mononuclear phagocyte system in homeostasis and disease: A role for heme oxygenase-1. Antioxid. Redox Signal. 2014, 20, 1770–1788. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  41. Riquelme, S.A.; Carreno, L.J.; Espinoza, J.A.; Mackern-Oberti, J.P.; Alvarez-Lobos, M.M.; Riedel, C.A.; Bueno, S.M.; Kalergis, A.M. Modulation of antigen processing by haem-oxygenase 1. Implications on inflammation and tolerance. Immunology 2016, 149, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Shen, K.; Jia, Y.; Wang, J.; Zhang, J.; Liu, K.; Wang, J.; Cai, W.; Li, J.; Li, S.; Zhao, M.; et al. Exosomes from adipose-derived stem cells alleviate the inflammation and oxidative stress via regulating Nrf2/HO-1 axis in macrophages. Free Radic. Biol. Med. 2021, 165, 54–66. [Google Scholar] [CrossRef] [PubMed]
  43. Watanabe-Matsui, M.; Muto, A.; Matsui, T.; Itoh-Nakadai, A.; Nakajima, O.; Murayama, K.; Yamamoto, M.; Ikeda-Saito, M.; Igarashi, K. Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2. Blood 2011, 117, 5438–5448. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Kong, J.S.; Yoo, S.A.; Kim, H.S.; Kim, H.A.; Yea, K.; Ryu, S.H.; Chung, Y.J.; Cho, C.S.; Kim, W.U. Inhibition of synovial hyperplasia, rheumatoid T cell activation, and experimental arthritis in mice by sulforaphane, a naturally occurring iso-thiocyanate. Arthritis Rheum. 2010, 62, 159–170. [Google Scholar] [CrossRef]
  45. Kwon, C.H.; Lee, C.Y.; Han, S.J.; Kim, S.J.; Park, B.C.; Jang, I.; Han, J.H. Effects of dietary supplementation of lipid-encapsulated zinc oxide on colibacillosis, growth and intestinal morphology in weaned piglets challenged with enterotoxigenic Escherichia coli. Anim. Sci. J. 2014, 85, 805–813. [Google Scholar] [CrossRef]
  46. Alsadi, R.; Boivin, M.; Ma, T. Mechanism of cytokine modulation of epithelial tight junction barrier. Front. Biosci. 2009, 14, 2765–2778. [Google Scholar] [CrossRef] [Green Version]
  47. Zhang, Z.; Ding, Y.; Dai, X.; Wang, J.; Li, Y. Epigallocatechin-3-gallate protects pro-inflammatory cytokine induced injuries in insulin-producing cells through the mitochondrial pathway. Eur. J. Pharmacol. 2011, 670, 311–316. [Google Scholar] [CrossRef]
Antioxidants 10 01915 g001 550
Figure 1. Chlorogenic acid (CGA) attenuates oxidative stress-induced inflammation and intestinal epithelium injury in weaned pigs. (A) Localization of the tight-junction protein claudin-1 by immunofluorescence staining. (B) Body weight. (C) Villus height of the jejunum in weaned pigs upon oxidative stress. (D) Serum concentrations of xylose. (E) Apoptosis of the intestinal epithelial cells. In each diagram, Q1-UL represents the percentage of nonviable and necrotic cells, Q1-UR represents the percentage of late apoptotic cells, Q1-LR represents the percentages of early apoptotic cells, and Q1-LL represents the percentage of live cells. (F) Abundances of malondialdehyde (MDA) and antioxidant enzymes in the intestinal mucosa. (G) Abundance of total antioxidative capability (T-AOC) and expressions of IL-10, IL-beta and TNF-alpha, respectively, in the intestinal mucosa. CON, pigs fed with basal diet; diquat, pigs fed with basal diet and challenged by diquat; DCGA, pigs fed with basal diet containing 1000 mg/kg CGA and challenged by diquat (n = 8). * p < 0.05, ** p < 0.01.
Figure 1. Chlorogenic acid (CGA) attenuates oxidative stress-induced inflammation and intestinal epithelium injury in weaned pigs. (A) Localization of the tight-junction protein claudin-1 by immunofluorescence staining. (B) Body weight. (C) Villus height of the jejunum in weaned pigs upon oxidative stress. (D) Serum concentrations of xylose. (E) Apoptosis of the intestinal epithelial cells. In each diagram, Q1-UL represents the percentage of nonviable and necrotic cells, Q1-UR represents the percentage of late apoptotic cells, Q1-LR represents the percentages of early apoptotic cells, and Q1-LL represents the percentage of live cells. (F) Abundances of malondialdehyde (MDA) and antioxidant enzymes in the intestinal mucosa. (G) Abundance of total antioxidative capability (T-AOC) and expressions of IL-10, IL-beta and TNF-alpha, respectively, in the intestinal mucosa. CON, pigs fed with basal diet; diquat, pigs fed with basal diet and challenged by diquat; DCGA, pigs fed with basal diet containing 1000 mg/kg CGA and challenged by diquat (n = 8). * p < 0.05, ** p < 0.01.
Antioxidants 10 01915 g001
Antioxidants 10 01915 g002 550
Figure 2. Protective effect of chlorogenic acid (CGA) on IPEC-J2 cells exposure to oxidative stress. (A) Localization of the tight-junction protein claudin-1 by immunofluorescence staining. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well and pretreated by CGA (100 µM) for 6 h, and the cells were then challenged by diquat (100 µM) for 3 h (n = 6). (B) Assays of cell viability. (C) Expression level of claudin-1. (D) Analysis of cell apoptosis by flow cytometric assays. In each diagram, Q1 represents the percentage of nonviable and necrotic cells, Q2 represents the percentage of late apoptotic cells, Q3 represents the percentages of early apoptotic cells, and Q4 represents the percentage of live cells. (E) Intracellular contents of oxygen reactive species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD). (F) qPCR analysis of the expression levels of critical inflammation-related molecules. (G) Western-blot analysis of the protein abundances of nuclear factor erythroid-derived-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). CON, cells without being treated; Diquat, cells were only treated by 100 µM diquat; CGA, cells were only treated by 100 µM CGA; DCGA, cells were pretreated by 100 µM CGA for 6 h and were then treated by 100 µM diquat for 3 h. * p < 0.05, ** p < 0.01.
Figure 2. Protective effect of chlorogenic acid (CGA) on IPEC-J2 cells exposure to oxidative stress. (A) Localization of the tight-junction protein claudin-1 by immunofluorescence staining. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well and pretreated by CGA (100 µM) for 6 h, and the cells were then challenged by diquat (100 µM) for 3 h (n = 6). (B) Assays of cell viability. (C) Expression level of claudin-1. (D) Analysis of cell apoptosis by flow cytometric assays. In each diagram, Q1 represents the percentage of nonviable and necrotic cells, Q2 represents the percentage of late apoptotic cells, Q3 represents the percentages of early apoptotic cells, and Q4 represents the percentage of live cells. (E) Intracellular contents of oxygen reactive species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD). (F) qPCR analysis of the expression levels of critical inflammation-related molecules. (G) Western-blot analysis of the protein abundances of nuclear factor erythroid-derived-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1). CON, cells without being treated; Diquat, cells were only treated by 100 µM diquat; CGA, cells were only treated by 100 µM CGA; DCGA, cells were pretreated by 100 µM CGA for 6 h and were then treated by 100 µM diquat for 3 h. * p < 0.05, ** p < 0.01.
Antioxidants 10 01915 g002
Antioxidants 10 01915 g003 550
Figure 3. Chlorogenic acid (CGA) attenuates oxidative stress-induced injury in IPEC-J2 cells via phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) signaling. (A) Localization of the tight-junction protein claudin-1 by immunofluorescence staining. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well (n = 6). (B) qPCR analysis of the expression levels of claudin-1. (C) Assays of cell viability. (D) Analysis of cell apoptosis by flow cytometric assays. (E) Intracellular contents of oxygen reactive species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD). (F) Western-blot analysis of critical signaling proteins involved in the PI3K/Akt pathway. CON, cells without being treated; Diquat, cells were only treated by 100 µM diquat; CGA, cells were only treated by 100 µM CGA; DCGA, cells were pretreated by 100 µM CGA for 6 h and were then treated by 100 µM diquat for 3 h. DCGAL, cells were pretreated by 10 µM LY294002 for 1 h and were then treated by 100 µM CGA and 100 µM diquat; LY294002, cells were only treated by 10 µM LY294002; CGAL, cells were pretreated by 10 µM LY294002 for 1 h and were then treated by 100 µM CGA; DL, cells were pretreated by 10 µM LY294002 for 1 h and were then treated by 100 µM diquat. * p < 0.05, ** p < 0.01.
Figure 3. Chlorogenic acid (CGA) attenuates oxidative stress-induced injury in IPEC-J2 cells via phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) signaling. (A) Localization of the tight-junction protein claudin-1 by immunofluorescence staining. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well (n = 6). (B) qPCR analysis of the expression levels of claudin-1. (C) Assays of cell viability. (D) Analysis of cell apoptosis by flow cytometric assays. (E) Intracellular contents of oxygen reactive species (ROS), malondialdehyde (MDA), and superoxide dismutase (SOD). (F) Western-blot analysis of critical signaling proteins involved in the PI3K/Akt pathway. CON, cells without being treated; Diquat, cells were only treated by 100 µM diquat; CGA, cells were only treated by 100 µM CGA; DCGA, cells were pretreated by 100 µM CGA for 6 h and were then treated by 100 µM diquat for 3 h. DCGAL, cells were pretreated by 10 µM LY294002 for 1 h and were then treated by 100 µM CGA and 100 µM diquat; LY294002, cells were only treated by 10 µM LY294002; CGAL, cells were pretreated by 10 µM LY294002 for 1 h and were then treated by 100 µM CGA; DL, cells were pretreated by 10 µM LY294002 for 1 h and were then treated by 100 µM diquat. * p < 0.05, ** p < 0.01.
Antioxidants 10 01915 g003
Antioxidants 10 01915 g004 550
Figure 4. Chlorogenic acid (CGA)-regulated heme oxygenase-1 (HO-1) expression suppresses NF-kappa-B inhibitor alpha (IκBα)/nuclear factor-κB (NF-κB) signaling in IEPC-J2 cell exposure to oxidative stress. (A) Analysis of cell apoptosis by flow cytometric assays. In each diagram, Q1 represents the percentage of nonviable and necrotic cells, Q2 represents the percentage of late apoptotic cells, Q3 represents the percentages of early apoptotic cells, and Q4 represents the percentage of live cells. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well (n = 6). (B) qPCR analysis of the expression levels of critical inflammation-related molecules. (C) Western-blot analysis of the abundance of heme oxygenase-1 (HO-1). (D) Western-blot analysis of critical signaling proteins involved in the IκBα/NF-κB pathway. CON, cells without being treated; diquat, cells were treated by 100 µM diquat; DCGA, cells were pretreated by 100 µM CGA for 6 h and were then treated by 100 µM diquat for 3 h; DCGAZ, cells were pretreated by 10 µM Zn-protoporphyrin-IX (ZnPPIX, the specific inhibitor of HO-1) and were then treated by 100 µM CGA and 100 µM diquat. * p < 0.05, ** p < 0.01.
Figure 4. Chlorogenic acid (CGA)-regulated heme oxygenase-1 (HO-1) expression suppresses NF-kappa-B inhibitor alpha (IκBα)/nuclear factor-κB (NF-κB) signaling in IEPC-J2 cell exposure to oxidative stress. (A) Analysis of cell apoptosis by flow cytometric assays. In each diagram, Q1 represents the percentage of nonviable and necrotic cells, Q2 represents the percentage of late apoptotic cells, Q3 represents the percentages of early apoptotic cells, and Q4 represents the percentage of live cells. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well (n = 6). (B) qPCR analysis of the expression levels of critical inflammation-related molecules. (C) Western-blot analysis of the abundance of heme oxygenase-1 (HO-1). (D) Western-blot analysis of critical signaling proteins involved in the IκBα/NF-κB pathway. CON, cells without being treated; diquat, cells were treated by 100 µM diquat; DCGA, cells were pretreated by 100 µM CGA for 6 h and were then treated by 100 µM diquat for 3 h; DCGAZ, cells were pretreated by 10 µM Zn-protoporphyrin-IX (ZnPPIX, the specific inhibitor of HO-1) and were then treated by 100 µM CGA and 100 µM diquat. * p < 0.05, ** p < 0.01.
Antioxidants 10 01915 g004
Antioxidants 10 01915 g005 550
Figure 5. Chlorogenic acid (CGA) attenuates tumor necrosis factor-α (TNF-α) induced inflammation and injury in IPEC-J2 cells. (A) Analysis of cell apoptosis by flow cytometric assays. In each diagram, Q1 represents the percentage of nonviable and necrotic cells, Q2 represents the percentage of late apoptotic cells, Q3 represents the percentages of early apoptotic cells, and Q4 represents the percentage of live cells. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well and pretreated by CGA (50 µM) for 6 h, and the cells were then challenged by TNF-α (50 ng/mL) for 3 h (n = 6). (B) Assays of cell viability. (C) qPCR analysis of the expressions of claudin-1. (D) Expressions of critical inflammation-related molecules. (E) Expressions of critical apoptosis-related proteins. (F) Western-blot analysis of critical signaling proteins involved in the NF-kappa-B inhibitor alpha (IκBα)/ nuclear factor-κB (NF-κB) pathway. CON, cells without being treated; TNF, cells were only treated by 50 ng/mL TNF-α; TCGA, cells were pretreated by 50 µM CGA for 6 h and were then treated by 50 ng/mL TNF-α for 3 h; CGA, cells were only treated by 50 µM CGA. * p < 0.05, ** p < 0.01.
Figure 5. Chlorogenic acid (CGA) attenuates tumor necrosis factor-α (TNF-α) induced inflammation and injury in IPEC-J2 cells. (A) Analysis of cell apoptosis by flow cytometric assays. In each diagram, Q1 represents the percentage of nonviable and necrotic cells, Q2 represents the percentage of late apoptotic cells, Q3 represents the percentages of early apoptotic cells, and Q4 represents the percentage of live cells. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well and pretreated by CGA (50 µM) for 6 h, and the cells were then challenged by TNF-α (50 ng/mL) for 3 h (n = 6). (B) Assays of cell viability. (C) qPCR analysis of the expressions of claudin-1. (D) Expressions of critical inflammation-related molecules. (E) Expressions of critical apoptosis-related proteins. (F) Western-blot analysis of critical signaling proteins involved in the NF-kappa-B inhibitor alpha (IκBα)/ nuclear factor-κB (NF-κB) pathway. CON, cells without being treated; TNF, cells were only treated by 50 ng/mL TNF-α; TCGA, cells were pretreated by 50 µM CGA for 6 h and were then treated by 50 ng/mL TNF-α for 3 h; CGA, cells were only treated by 50 µM CGA. * p < 0.05, ** p < 0.01.
Antioxidants 10 01915 g005
Antioxidants 10 01915 g006 550
Figure 6. Chlorogenic acid (CGA) suppresses tumor necrosis factor-α (TNF-α) induced inflammation and injury that is independent on the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt)/ heme oxygenase-1 (HO-1) pathway. (A) Localization of the tight-junction protein claudin-1 by immunofluorescence staining. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well (n = 6). (B) Assays of cell viability. (C) qPCR expressions of claudin-1. (D) Analysis of cell apoptosis by flow cytometric assays. In each diagram, Q1 represents the percentage of nonviable and necrotic cells, Q2 represents the percentage of late apoptotic cells, Q3 represents the percentages of early apoptotic cells, and Q4 represents the percentage of live cells. (E) Expressions of critical inflammation-related molecules. (F) Western-blot analysis of critical signaling proteins involved in the NF-kappa-B inhibitor alpha (IκBα)/nuclear factor-κB (NF-κB) pathway. CON, cells without being treated; TNF, cells were treated by 50 ng/mL TNF-α; TCGAZ, cells were pretreated by 10 µM Zn-protoporphyrin-IX (ZnPPIX, the specific inhibitor of HO-1) for 1 h and were then treated by 50 µM CGA and 50 ng/mL TNF-α; TBAY, cells were pretreated by 20 µM (E)3-[(4-methylphenyl)-sulfonyl]-2-propenenitrile (BAY11-7082, the specific NF-κB inhibitor) and were then treated by 50 ng/mL TNF-α; CGA, cells were only treated by 50 µM CGA; BAY, cells were only treated by 20 µM BAY11-7082. * p < 0.05, ** p < 0.01.
Figure 6. Chlorogenic acid (CGA) suppresses tumor necrosis factor-α (TNF-α) induced inflammation and injury that is independent on the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt)/ heme oxygenase-1 (HO-1) pathway. (A) Localization of the tight-junction protein claudin-1 by immunofluorescence staining. IPEC-J2 cells were plated in 24-well plates at a density of 1 × 105 cells/well (n = 6). (B) Assays of cell viability. (C) qPCR expressions of claudin-1. (D) Analysis of cell apoptosis by flow cytometric assays. In each diagram, Q1 represents the percentage of nonviable and necrotic cells, Q2 represents the percentage of late apoptotic cells, Q3 represents the percentages of early apoptotic cells, and Q4 represents the percentage of live cells. (E) Expressions of critical inflammation-related molecules. (F) Western-blot analysis of critical signaling proteins involved in the NF-kappa-B inhibitor alpha (IκBα)/nuclear factor-κB (NF-κB) pathway. CON, cells without being treated; TNF, cells were treated by 50 ng/mL TNF-α; TCGAZ, cells were pretreated by 10 µM Zn-protoporphyrin-IX (ZnPPIX, the specific inhibitor of HO-1) for 1 h and were then treated by 50 µM CGA and 50 ng/mL TNF-α; TBAY, cells were pretreated by 20 µM (E)3-[(4-methylphenyl)-sulfonyl]-2-propenenitrile (BAY11-7082, the specific NF-κB inhibitor) and were then treated by 50 ng/mL TNF-α; CGA, cells were only treated by 50 µM CGA; BAY, cells were only treated by 20 µM BAY11-7082. * p < 0.05, ** p < 0.01.
Antioxidants 10 01915 g006
Antioxidants 10 01915 g007 550
Figure 7. Model of proposed mechanism of chlorogenic acid (CGA)-attenuated intestinal inflammation and injury induced by oxidative stress. CGA protects the intestinal epithelium against oxidative stress-induced injury via regulating the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt)/ nuclear factor erythroid-derived-related factor 2 (Nrf2) signaling pathway; CGA attenuates the intestinal inflammation by co-regulating the PI3K/Akt/heme oxygenase-1 (HO-1) and NF-kappa-B inhibitor alpha (IκBα)/nuclear factor-κB (NF-κB) signaling pathway.
Figure 7. Model of proposed mechanism of chlorogenic acid (CGA)-attenuated intestinal inflammation and injury induced by oxidative stress. CGA protects the intestinal epithelium against oxidative stress-induced injury via regulating the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt)/ nuclear factor erythroid-derived-related factor 2 (Nrf2) signaling pathway; CGA attenuates the intestinal inflammation by co-regulating the PI3K/Akt/heme oxygenase-1 (HO-1) and NF-kappa-B inhibitor alpha (IκBα)/nuclear factor-κB (NF-κB) signaling pathway.
Antioxidants 10 01915 g007
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Chen, J.; Luo, Y.; Li, Y.; Chen, D.; Yu, B.; He, J. Chlorogenic Acid Attenuates Oxidative Stress-Induced Intestinal Epithelium Injury by Co-Regulating the PI3K/Akt and IκBα/NF-κB Signaling. Antioxidants 2021, 10, 1915. https://doi.org/10.3390/antiox10121915

AMA Style

Chen J, Luo Y, Li Y, Chen D, Yu B, He J. Chlorogenic Acid Attenuates Oxidative Stress-Induced Intestinal Epithelium Injury by Co-Regulating the PI3K/Akt and IκBα/NF-κB Signaling. Antioxidants. 2021; 10(12):1915. https://doi.org/10.3390/antiox10121915

Chicago/Turabian Style

Chen, Jiali, Yuheng Luo, Yan Li, Daiwen Chen, Bing Yu, and Jun He. 2021. "Chlorogenic Acid Attenuates Oxidative Stress-Induced Intestinal Epithelium Injury by Co-Regulating the PI3K/Akt and IκBα/NF-κB Signaling" Antioxidants 10, no. 12: 1915. https://doi.org/10.3390/antiox10121915

APA Style

Chen, J., Luo, Y., Li, Y., Chen, D., Yu, B., & He, J. (2021). Chlorogenic Acid Attenuates Oxidative Stress-Induced Intestinal Epithelium Injury by Co-Regulating the PI3K/Akt and IκBα/NF-κB Signaling. Antioxidants, 10(12), 1915. https://doi.org/10.3390/antiox10121915

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop